ArticleSurgical neurology international2026
An intractable case of primary intra-axial central nervous system Rosai-Dorfman disease.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rosai-Dorfman disease (RDD) is a rare histiocytic disorder with a typically benign clinical course. However, isolated involvement of the central nervous system (CNS), particularly in the form of primary intra-axial disease, is exceedingly rare. We report an intractable case of intra-axial CNS RDD with an atypical clinical presentation. Case Description: A woman in her 60s presented with gradually progressive left hemiplegia. Magnetic resonance imaging demonstrated a solid intra-axial mass (30-mm diameter) in the right frontal lobe, located in the primary motor cortex, with homogeneous gadolinium enhancement and extensive peritumoral edema. Given its eloquent location, an open biopsy was performed, and histopathological examination confirmed the diagnosis of RDD. Treatment with corticosteroids and cladribine resulted in temporary tumor regression, but the lesion subsequently progressed and exhibited an intractable clinical course. The patient developed worsening neurological deficits and additional intracranial lesions, and she ultimately died approximately 30 months after the disease onset. Conclusion: Two cases of death directly caused by intra-axial CNS RDD were previously reported; in both cases, surgical treatment had not been possible. In our case, the tumor was in the primary motor area and challenging to resect. Taken together, total surgical resection may be required to achieve disease control in patients with intra-axial CNS RDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.